chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started the same night I received vaccine. Occasional, but frequent racing heart beat. A harder hard beat. Chest pains. Unable to sleep because heart is racing.  Unable to slow heart rate at times lasting throughout the whole night. Sometimes irregular heart beat. I could workout and be fine, but symptoms would get worse hours after working out and remain worse for a few days after. This has lasted a few months after 1 dose. I was miserable and scared and it seems to be going away as far as my daily life is concerned.. however I am unsure if I workout, if it will come back for a few days like it has recently when I worked out.
Eye itching 6 hours after administration lasting for 24 hours. Injection site reaction: Entire upper arm reddening lasting for 72 hours after admin. Dissipated by half by 4 days after.
Saddle Embolus of Pulmonary Artery with acute cor pulmonale. Shortness of breath on exertion and talking. speaks in 2-3 word sentences. tachypneic and clear to auscultation bilaterally. Well's Score = 7.5 Pain of lower left extremity. began ~8/25/21. limiting ability to walk and greatly reducing activity over past week. rates pain 8/10. right calf circumference greater than left and mildly tender to palpitation. pulses 2+ and symmetric. Heparin bolus and drip initiated in ED due to short half-life, kidney function, and potential need for invasive thrombectomy.
Patient stated immediate pain right deltoid after vaccine; two weeks later presented to health center with right shoulder pain for 2 weeks.
- Patient received 2nd dose pfizer accompanied by parent and family member. Reported loss of hearing in one ear and reported not feeling well. - Patient ambulated to the observation area and within a few minutes, she felt nauseous. Mother assisted patient to bathroom and patient became lightheaded.   - Safety officer assisted patient to wheelchair and wheeled into Special Obs area and put into supine position - Vitals taken every 5 minutes for 15 minutes. Patient was able to sit up afterwards, felt better, and blood pressure was normal before leaving.  - Counseled patient to contact PCP if any further reaction or call 911 if emergency.
Patient described extreme pain when vaccination was given/pt raised out of chair. Since that time has experienced extreme soreness/tenderness of shoulder radiating into neck. Described shot being given very high up on shoulder. Has been using warm compressed every night.
Itchy; Red rash; Arm swelled up; Very red; Hot; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported ).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up), ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness) and VACCINATION SITE RASH (Red rash). On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy). On 26-Jan-2021, PERIPHERAL SWELLING (Arm swelled up) had resolved. At the time of the report, ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE RASH (Red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported   Treatment using   acetaminophen was reported Usage of ice was reported   Reporter did not allow further contact
This office was informed today that patient was taken to emergency room last night for fever of 102 degrees.
1/29/21 - 6:00 am - awakened with following - - L arm pain, edema, erythema and inability to lift L arm - lasted 3 days - severe sleepiness and malaise -persisted x 1 day - major increase in asthma symptoms - onset asthma age 12, significant daily symptons through early 90's until started on inhaled steroid.  Since then, progressive improvement.  Twenty years ago required Pulmicort flexihaler 2x per day.  In January 2021 prior to vaccine required same inhaler 1 - 3x per week in winter, 1-2 puffs per month in summers.  Symptoms have improved but persist needing 1 dose of inhaler per day.
12/9/21 20:30- Dizziness, nausea, fatigue 12/10/21 03:00 - Fever of 102, shortness of breathe, migraine, seizure, nausea, weakness, dehydration
Pt vaccinated on 7/8/10, MMR, Varicella, HIB, PREVNAR, HIB. Mother states patient had fever of 102 axillary in evening of vaccination, was given TYLENOL and Ibuprofen which reduced fever to normal for 4 hrs but returned to 102 after 4 hours. Mom states she kept patient medicated to keep fever down and he was afebrile after 48 hrs.
Pt. presented with a red rash on her left arm above her elbow that was warm to the touch.
Throat soreness; Pain in Right arm; Neck is staying stiff to move; Concentration for daily stuff has been really off; Very forgetful. I can't remember half the time what I'm doing.; Redness; Nausea; Itchy; Extreme pain from arm going up to top of shoulder into neck; Extreme pain from arm going up to top of shoulder into neck; Body aches; Increased cough; Hot; Arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelling), VACCINATION SITE WARMTH (Hot), OROPHARYNGEAL PAIN (Throat soreness), COUGH (Increased cough) and ERYTHEMA (Redness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fruit allergy (Fruits), Vegetable allergy (Vegi's), Drug allergy (Compazine) and Asthma (Patient was coughing and using inhaler more.) since 1967. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR HFA) and ALBUTEROL SULFATE for Asthma.    On 22-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PERIPHERAL SWELLING (Arm swelling). On 22-May-2021, the patient experienced VACCINATION SITE WARMTH (Hot), COUGH (Increased cough), PRURITUS (Itchy), NECK PAIN (Extreme pain from arm going up to top of shoulder into neck), ARTHRALGIA (Extreme pain from arm going up to top of shoulder into neck) and MYALGIA (Body aches). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Throat soreness), ERYTHEMA (Redness), PAIN IN EXTREMITY (Pain in Right arm), MUSCULOSKELETAL STIFFNESS (Neck is staying stiff to move), DISTURBANCE IN ATTENTION (Concentration for daily stuff has been really off), MEMORY IMPAIRMENT (Very forgetful. I can't remember half the time what I'm doing.) and NAUSEA (Nausea). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm swelling), VACCINATION SITE WARMTH (Hot), OROPHARYNGEAL PAIN (Throat soreness), COUGH (Increased cough), PRURITUS (Itchy), MUSCULOSKELETAL STIFFNESS (Neck is staying stiff to move), DISTURBANCE IN ATTENTION (Concentration for daily stuff has been really off), MEMORY IMPAIRMENT (Very forgetful. I can't remember half the time what I'm doing.), NECK PAIN (Extreme pain from arm going up to top of shoulder into neck), ARTHRALGIA (Extreme pain from arm going up to top of shoulder into neck) and MYALGIA (Body aches) had not resolved and ERYTHEMA (Redness), PAIN IN EXTREMITY (Pain in Right arm) and NAUSEA (Nausea) had resolved. Not Provided          Treatment also included warm soak and ice placed on arm.   This case was linked to MOD-2021-090434 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jun-2021: Follow-up received on 27-JUN-2021: Contains No New Information
Pt recvd 2 injects & 6 hrs p/2nd inject had rash & itching over body; pt was seen by MD;
Potential preparation error of doses administered to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Potential preparation error of doses administered to patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Potential preparation error of doses administered to patients). On 29-Oct-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Potential preparation error of doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.  Pharmacist left the needle in the vial and and drew up 4 doses from that one needle by attaching the syringes to the one needle to draw up the dose and then re-attaching another needle to administer the dose to 4 patients.   Most recent FOLLOW-UP information incorporated above includes: On 09-Nov-2021: Additional information received and reporter information updated On 09-Nov-2021: Non-Significant Follow up contains no new information.
Fever I?ve 102 for two days. Couldn?t get out of bed. Severe and ongoing exhaustion. Respiratory labor, Chills, Nausea.    I was in bed for almost 3-days with the first shot and it took over two weeks to fight severe exhaustion.
1 of 3 pts ( of the first 5 doses of Tetramune administered from vial) who devel an inject site react of induration, erythema & warm to touch w/in 24 hrs; react approx the size of a fifty-cent piece; no treatment initiated; pt recovered;
2 wks after MMR was given, patient complained of arthralgia in shoulders, hands, ankles - atypical for her, although she was recently doing physical work around her house at same time, lasted 3 wks with no further complaints, completely resolved.
temperature excursion for PROQUAD/vaccines that were administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies.  On 11-SEP-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rha) (PROQUAD) 0.5 mL subcutaneously (SQ) (lot number T016990 has been verified to be valid, expiration date reported and established as 11-NOV-2021) as prophylaxis.  The vaccine was exposed to a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit (7.3°F) during a time frame of 37 minutes (product storage error).   Aditionally, it was reported that other doses of the vaccine experienced temperature excursions of 6 degrees Fahrenheit to 14 degrees Fahrenheit (9.9°F) during a time frame of 2 hours, 11 minutes, and 6 degrees Fahrenheit to 14 degrees Fahrenheit (6.6°F) during a time frame of 59 minutes.
vaccine was in refrigerator post beyond use date and then administered; 1 dose administered after vaccine reached Beyond Use Date (BUD); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 dose administered after vaccine reached Beyond Use Date (BUD)) and PRODUCT STORAGE ERROR (vaccine was in refrigerator post beyond use date and then administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (1 dose administered after vaccine reached Beyond Use Date (BUD)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was in refrigerator post beyond use date and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 dose administered after vaccine reached Beyond Use Date (BUD)) and PRODUCT STORAGE ERROR (vaccine was in refrigerator post beyond use date and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.  Off label stability date was reported as 09-Oct-2021. The reporter asked whether if any of these doses were still viable or would the patients need to be revaccinated again.
fever 103-104 3 hrs p/immun & diarrhea 3-4 hrs following immun; pt refused to suck; mom reports unable to gets fluids into pt; pt fussy;
This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 9, 2021, patient experienced feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache. At the time of the report, feeling abnormal (felt loopy), abnormal thinking (couldn't think straight for a day) and pounding headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant products usage and treatment details not included.
seizure reported in pt receiving Fluogen necessary due to bronchial asthma & neurological problems & 82 hrs later had seizure, taken to ER, T 101, more seizures,
pt experienced lip swelling and mouth itching, she was given 25mg of Benadryl PO and the symptoms resolved within 60 minutes
Gave pt FLUZONE HIGH-DOSE 2/27/19 no side effects noted. He feels fine and stated no side effects.
October 10, 2018, I have the shingles vaccine at the same time as the flu vaccine. I was sick for 3 days with headaches, body aches and arm pain. Body aches went away and so did arm pain after 3 days. Day four still had headache, arm started hurting worse in a higher location, 5 teeth started hurting when eating hot or cold food, body broke out in a rash, body aches, neck swelling. Talked to pharmacy, they said it wasn't the vaccine. Saw Dr. she said it wasn't Vaccine. Saw Nurse Practitioner said it could be vaccine but gave me Lorazepam, did not help at all went again back today still all these symptoms and they said call you. Been to doctors 4 times now and no help to make the symptoms go away!
Non-ischemic dilated cardiomyopathy with congestive heart failure, admission with an LVEF of 15%.  Seen by myself on August 7, 2021 with a persistent ejection fraction.
The Moderna vaccine has thrown my autoimmune disorder into over drive and I am miserable had to take cortisteriods and the side effects are awful
Typhoid pills started 8-12-13. Severe abdominal pain and diarrhea starting with first pill. Seemed to improve 2 days after last pill. Taken every other day x 4 pills - correctly as prescribed.
Hands and shoulders became increasingly painful during the night to where it would wake me up.  Hand joints became increasingly swollen making it hard to grasp things.  Mornings were the worst and then the pain would subside by midmorning.  It slowly started to resolve in September and by December the left shoulder finally stopped hurting.
Dizzy; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "recovered" (2021), described as "Dizzy"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional Information: Reporter stated, his sister got the same shot the day before he did at the same place and she said hers made her feel dizzy for 2 days but that was her only reaction other than a sore arm. All he knew about his sister's experience was that, it made her dizzy. He stated that he was not able to answer all these questions for his sister's experience.  No follow-up attempts are possible. No further information is expected.
no rxn reported by mom @ 5PM time of telephone call informing mom OPV needs to be repeated at age 12mo of age;report submitted because OPV administered too soon;
When vaccine given LD there was an actual spurting as if arterial of blood, lasting almost two seconds. The blood shot out an inch and a half away from pt's skin. He then became very shaky, gasping, eyes rolling. He has a fear of blood. He laid down and felt cold and shaky, while simultaneously laughing at the blood event. He did recover after about ten minutes. He has some psychiatric Dx and he almost looked like he was about to have a non epileptic seizure but he didn't lose consciousness.
This vaccine (bivalent) was given as the patient's 2nd dose. The patient should have received the 2nd monovalent vaccine today.
Rash on left deltoid area where inj administered stomach upset that evening and through next two days, then vomiting x 1 day.
This spontaneous report was received from a doctor of pharmacy regarding two female patients of unknown age. On an unknown date, the patient were vaccinated with 0.65 ml ZOSTAVAX subcutaneously (lot number was not reported). No concomitant medications were reported. On an unknown date, the patient received ZOSTAVAX and got a rash at injection site that was itchy and a red patch, no treatment was given. The patient sought medical attention (visit to pharmacy). On an unknown date, the patient recovered from the events. This is one of several reports from the same source. Additional information has been requested.
Mom reports pt devel rash, t102, vomiting, & became very lethargic 2wks post vax; Pt seen @ ER & dx as MMR rxn vs rock mtn spotted fever; tx meds; no definite dx was ever made;
After vaccine patient noticed site was irritated, sore, red. Felt a little better next few days but still red. Redness spread over course of a week down patient's arm. Warm to the touch.
Left arm was sore; hot at the injection site; arm red on inner part of arm to elbow; These specific side effects subsided after one week.  On-going effects is loss of range of motion in left arm;  unable to put weight or sleep on left side at night due to on-going pain in upper part of arm.
The pt was irritable the day of the vaccines with a breath holding spell at home and became pale. The pt also experienced a low grade fever of 100.4.
Itchy/Scratchy tongue and lips within 10 minutes of vaccine. Symptoms lasted for about 2-3 hours. Developed rash on RLE that was itchy, red, and bumpy around 6 hours after receiving the injection. Those symptoms lasted for about 2 hours. Breastfeeding baby developed cold symptoms (sneezing, coughing, runny nose) about 4-5 days after mom received vaccine. Symptoms are still ongoing as of day 7 after receiving vaccine.
Patient was given and expired/invalid dose of the vaccine as it was drawn up >6 hours from which it was given.
fever 105w/foaming @ mouth brought to Er @ hos & was given Pediaprofin & ATB for poss ear infection;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-FEB-2016, the patient was vaccinated with the expired dose of VARIVAX (Merck) (lot # reported as J006162 (verified to be non-valid lot # for VARIVAX (Merck), expiration date 20-MAY-2015; dose and route of administration were not reported). No adverse effect was reported. Additional information has been requested.
Continued injection site pain, fatigue, constant headache, body aches, and nausea
At 1700 the day of the vaccination, hives developed on the forearms and upper extremities on both the right and left arms. At 1800, a fever of 100 degrees developed with a headache.  No shortness of breath, no difficulty breathing, no abominal pain.
12Jul96 Pt recv 1 dose varicella vax. 03Feb98 Pt devel chickenpox.Low grade fever.
Incorrect vaccine for age--patient given first dose Moderna on 3/9.  Received second dose Moderna as per CDC guidance.
11/26/22 presents to ED for "fever". PMHx of "atrial fibrillation, CAD, CHF, CVA"
Pt recv vax on 10/13/98; on 10/14/98 pt exp tingling in fingers &toes w/ ascending paresthesia in LA. Pt still has sxs.
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age with trigeminal neuralgia. On 08-DEC-2011 the patient was vaccinated with ZOSTAVAX single 0.65 ml, subcutaneous (lot number not reported). No other concomitant medications were reported. Physician reported that on an unknown date, patient experienced blistering and rash on face. Reporter noted that the patient "had had a like experience (this is not clear) "over one year ago. The outcome of blistering and rash on face was reported as recovering/resolving. The relationship between ZOSTAVAX and the events was unknown. The patient did not receive any treatment for the adverse events. The patient sought unspecified medical attention. Additional information has been requested.
The patient also states she had COVID in December 2022; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (The patient also states she had COVID in December 2022) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Drug allergy (she is allergic to thimerosal).    On 01-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2022, the patient experienced COVID-19 (The patient also states she had COVID in December 2022). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (The patient also states she had COVID in December 2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient stated that she had Moderna all the way through. She wants to know if the new vaccine had thimerosal because she was allergic to thimerosal. The patient also states she had COVID in December 2022. She ended up taking Paxlovid at the time. She wants to make sure that it was ok to take Spikevax.  The patient was unsure whether her Moderna dose on 1Jul2022 was monovalent or bivalent vaccine.  Patient had Moderna on 12Feb2021, Moderna on 12Mar2021, and Moderna on 21Nov2021 Moderna on 01Jul2022 (lot number 014B22A). Concomitant medications were not reported.